BIOGEN INC. is 9.4x more valuable than Adaptive Biotechnologies Corp by market capitalization ($28.73 B vs $3.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADPT | BIIB |
|---|---|---|
| Market cap | $3.05 B | $28.73 B |
| US-listed rank | #1800 | #480 |
| Revenue (latest FY) | $276.98M | $9.89B |
| Net income (latest FY) | -$59.50M | $1.29B |
| Net margin | -21.5% | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 764 | 2,690 |
BIOGEN INC. is 9.4x more valuable than Adaptive Biotechnologies Corp by market capitalization ($28.73 B vs $3.05 B).
In their latest fiscal years, Adaptive Biotechnologies Corp reported $276.98M in revenue while BIOGEN INC. reported $9.89B.
Full pages: Adaptive Biotechnologies Corp and BIOGEN INC., or browse the full rankings.